Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction
- PMID: 23237130
- PMCID: PMC3607508
- DOI: 10.1016/j.ahj.2012.10.005
Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction
Abstract
Background: Although controversial, reducing low-density lipoprotein cholesterol (LDL-C) to target levels remains a common therapeutic goal after acute myocardial infarction (AMI). We sought to illuminate patient and provider characteristics associated with LDL-C goal nonattainment after AMI.
Methods: In an observational registry of 24 US hospitals, we included 366 patients with AMI who had baseline LDL-C levels ≥100 mg/dL and underwent 6-month fasting LDL-C reassessment. Our primary outcome was failure to reach the guideline-recommended LDL-C goal of <100 mg/dL at 6 months post-AMI.
Results: One in 3 patients with AMI with initially elevated LDL-C failed to attain LDL-C goal at 6 months. Compared with those who attained LDL-C goal, those who did not were more often discharged without a statin (21% vs 9%, P < .001), despite only 4% having documented contraindications. Patients not achieving LDL-C goal also more frequently discontinued statin use by 6 months (24% vs 6%, P < .001). Multivariable modeling (c index, 0.78) revealed the absence of a statin prescription at discharge and lack of persistence on statin therapy as the strongest independent factors associated with failure to reach LDL-C goal. Additional independent risk factors were patient report of not consistently adhering to prescribed medications, not participating in cardiac rehabilitation, nonwhite race, and lack of insurance.
Conclusions: One-third of patients with AMI with baseline hyperlipidemia do not attain the LDL-C goal of <100 mg/dL at 6 months. Our findings support targeted interventions in the transition of AMI care to promote affordable statin prescription at discharge, medication persistence and adherence, and cardiac rehabilitation participation.
Copyright © 2013 Mosby, Inc. All rights reserved.
Figures


Similar articles
-
Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.Am J Cardiol. 2017 Jul 15;120(2):174-180. doi: 10.1016/j.amjcard.2017.04.003. Epub 2017 Apr 27. Am J Cardiol. 2017. PMID: 28532771
-
Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.PLoS One. 2015 Jun 17;10(6):e0127835. doi: 10.1371/journal.pone.0127835. eCollection 2015. PLoS One. 2015. PMID: 26083546 Free PMC article. Clinical Trial.
-
Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction.Clin Cardiol. 2012 Apr;35(4):211-8. doi: 10.1002/clc.20984. Epub 2011 Nov 18. Clin Cardiol. 2012. PMID: 22102488 Free PMC article.
-
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
-
2017 Taiwan lipid guidelines for high risk patients.J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. J Formos Med Assoc. 2017. PMID: 28242176 Review.
Cited by
-
The Clinical Outcomes Based on the Achievement of Low-Density Lipoprotein Cholesterol Targets after ST Elevation Myocardial Infarction.J Clin Med. 2019 Dec 28;9(1):79. doi: 10.3390/jcm9010079. J Clin Med. 2019. PMID: 31905621 Free PMC article.
-
Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction.Korean Circ J. 2017 Jan;47(1):31-35. doi: 10.4070/kcj.2015.0266. Epub 2016 Nov 24. Korean Circ J. 2017. PMID: 28154588 Free PMC article.
-
Undertreatment or Overtreatment With Statins: Where Are We?Front Cardiovasc Med. 2022 Apr 29;9:808712. doi: 10.3389/fcvm.2022.808712. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571155 Free PMC article. Review.
-
Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population.Am J Epidemiol. 2014 Jun 1;179(11):1293-300. doi: 10.1093/aje/kwu060. Epub 2014 Apr 16. Am J Epidemiol. 2014. PMID: 24743066 Free PMC article.
-
Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention.Medicine (Baltimore). 2017 Jan;96(1):e5469. doi: 10.1097/MD.0000000000005469. Medicine (Baltimore). 2017. PMID: 28072688 Free PMC article.
References
-
- Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2008;51:210–47. - PubMed
-
- Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2004;44:E1–E211. - PubMed
-
- Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1–e157. - PubMed
-
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–97. - PubMed
-
- Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44:720–32. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical